Ornim Revenue and Competitors
Estimated Revenue & Valuation
- Ornim's estimated annual revenue is currently $2.8M per year.
- Ornim's estimated revenue per employee is $251,000
Employee Data
- Ornim has 11 Employees.
- Ornim grew their employee count by -27% last year.
Ornim's People
Name | Title | Email/Phone |
---|
Ornim Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Ornim?
Ornim Medical is an Israeli bio-medical high-technology company specializing in clinical research, development, and distribution of the highest quality monitoring devices for cerebral and tissue blood flow. Its two products, the CerOxâ„¢ and the c-FLOWâ„¢ are based on the patented UTLightTâ„¢ technology and can be used in most areas where CBF is needed to be monitored. Ornim Medical provides physicians with the most advanced monitoring tools to help direct safe and decisive patient care when the perfusion of vital tissue is at stake. Ornim's CerOxâ„¢ monitor is the only device enabling simultaneous, non-invasive measurement of blood flow and oxygen saturation, while the recently FDA approved c-FLOWâ„¢ is a pared down version used to measure the CBF itself only. The use of either of these products (depending on the clinical setting) is key to understand perfusion, helping direct treatment and lower the cost of patient care. Ornim Medical's patented UTLightâ„¢ technology employs the combination of light and ultrasound to provide a non-invasive measure of regional blood oxygen saturation and blood flow. UTLightâ„¢ technology is unique among all other commercially available NIRS technologies, since it also analyzes the light speckle signal and does not rely solely on the intensity of light reaching the detector. Ornim Medical's unique technology is protected by 13 granted worldwide patents. For more information, please visit our website at www.ornim.com
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.8M
Revenue (est)
-27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ornim News
Ornim Medical, Medtronic, CASMED, ISS Photonics K.K., Nonin Medical, Hamamatsu, Masimo. This Cerebral Somatic Oximeters Market report covers...
Ornim Medical, Medtronic, CASMED, ISS Photonics K.K., Nonin Medical, Hamamatsu, Masimo. The report provides a good overview of the key...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | 0% | N/A |
#2 | $2.9M | 15 | 7% | N/A |
#3 | $1.6M | 18 | 6% | N/A |
#4 | $1.6M | 18 | N/A | N/A |
#5 | $6.6M | 29 | 81% | N/A |